{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:45:08Z","timestamp":1792251908118,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Contactin-associated protein-like 2 (CASPR2) antibody-related neurological syndrome is well defined in adults, while data in children is rare. We perform this case series and literature review to ascertain the clinical features of this disorder in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentations<\/jats:title>\n                    <jats:p>We describe three cases who were diagnosed with CASPR2 antibody-related neurological syndrome, and then systematically characterized clinical features, therapeutic responses, and outcomes in 64 patients in literature. Among the 67 patients, the median age was 8.4 years (range 0.5\u201318), with a male predominance (65.7%). The most characteristic symptoms of CASPR2 antibody-related neurological syndrome include psychiatric abnormalities (68.7%), sleep disorders (55.2%), dysautonomia (44.8%), movement disorders (43.3%), seizures (41.8%), neuropathic pain (34.3%), and cognitive disturbances (31.3%). Autoimmune encephalitis (AE, 62.7%) was most frequent, followed by Morvan syndrome (MoS, 26.9%) and peripheral nerve hyperexcitability (PNH, 7.5%). CASPR2 antibodies are typically detected in serum (85.1%), but rarely in CSF exclusively (3.0%). Investigations revealed abnormalities in CSF analysis (22.9%; 13 AE, 5 MoS), brain MRI (24.1%; 11 AE, 3 MoS), and EEG (67.3%; 26 AE, 7 MoS). Neoplasm was not found in our case series and literature review. Regarding treatment, 46 patients received first-line immunotherapy alone, while 5 required second-line treatment. Immunotherapy demonstrated highly effective, with 95.8% achieving a favorable outcome (mRS score\u2009\u2264\u20092) and a low recurrence rate of 5.1%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We therefore recommend that all children presenting with new-onset psychiatric abnormalities, sleep disorders, dysautonomia, movement disorders, seizures, neuropathic pain, and cognitive disturbances should be suspected of having CASPR2 antibody-related neurological syndrome. Neoplastic processes are rare in pediatric patients. Early recognition of the disease is important because it responds well to immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06549-4","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:34:53Z","timestamp":1770291293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CASPR2 antibody-related neurological syndromes in children: three cases report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Long-Ying","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Qiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"4","key":"6549_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0896-6273(00)81049-1","volume":"24","author":"S Poliak","year":"1999","unstructured":"Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, et al. Caspr2, a new member of the neurexin superfamily, is localized at the Juxtaparanodes of myelinated axons and associates with K\u2009+\u2009channels. Neuron. 1999;24(4):1037\u201347.","journal-title":"Neuron"},{"issue":"5","key":"6549_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/glia.22968","volume":"64","author":"B Hivert","year":"2016","unstructured":"Hivert B, Pinatel D, Labasque M, Tricaud N, Goutebroze L, Faivre-Sarrailh C. Assembly of Juxtaparanodes in myelinating DRG culture: differential clustering of the Kv1\/Caspr2 complex and scaffolding protein 4.1B. Glia. 2016;64(5):840\u201352.","journal-title":"Glia"},{"issue":"11","key":"6549_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/dmcn.14179","volume":"61","author":"S Surana","year":"2019","unstructured":"Surana S, Kumar R, Pitt M, Hafner P, Mclellan A, Davidson J, et al. Acquired neuromyotonia in children with CASPR2 and LGI1 antibodies. Dev Med Child Neurol. 2019;61(11):1344\u20137.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"6549_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97(2):839\u201387.","journal-title":"Physiol Rev"},{"key":"6549_CR5","doi-asserted-by":"crossref","unstructured":"Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E. er al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011;69(2):303-11.","DOI":"10.1002\/ana.22297"},{"issue":"11","key":"6549_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1212\/WNL.0000000000001922","volume":"85","author":"Y Hacohen","year":"2015","unstructured":"Hacohen Y, Singh R, Rossi M, Lang B, Hemingway C, Lim M, et al. Clinical relevance of voltage-gated potassium channel\u2013complex antibodies in children. Neurology. 2015;85(11):967\u201375.","journal-title":"Neurology"},{"issue":"4","key":"6549_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"Pt 8","key":"6549_CR8","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/awf178","volume":"125","author":"IK Hart","year":"2002","unstructured":"Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002;125(Pt 8):1887\u201395.","journal-title":"Brain"},{"issue":"5 Pt 2","key":"6549_CR9","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S0035-3787(04)71010-3","volume":"160","author":"J Newsom-Davis","year":"2004","unstructured":"Newsom-Davis J. Neuromyotonia Rev Neurol (Paris). 2004;160(5 Pt 2):S85\u20139.","journal-title":"Neuromyotonia Rev Neurol (Paris)"},{"issue":"10","key":"6549_CR10","doi-asserted-by":"publisher","first-page":"e01793","DOI":"10.1002\/brb3.1793","volume":"10","author":"P Ghimire","year":"2020","unstructured":"Ghimire P, Khanal UP, Gajurel BP, Karn R, Rajbhandari R, Paudel S, et al. Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in asia: A systematic review. Brain Behav. 2020;10(10):e01793.","journal-title":"Brain Behav"},{"issue":"1","key":"6549_CR11","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41598-023-28268-x","volume":"13","author":"L Wu","year":"2023","unstructured":"Wu L, Cai F, Zhuo Z, Wu D, Zhang T, Yang H, et al. CASPR2 antibody associated neurological syndromes in children. Sci Rep. 2023;13(1):2073.","journal-title":"Sci Rep"},{"issue":"5","key":"6549_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","volume":"89","author":"SNM Binks","year":"2018","unstructured":"Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry. 2018;89(5):526\u201334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"6549_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","volume":"13","author":"A Van Sonderen","year":"2017","unstructured":"Van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol. 2017;13(5):290\u2013301.","journal-title":"Nat Rev Neurol"},{"key":"6549_CR14","doi-asserted-by":"publisher","first-page":"652864","DOI":"10.3389\/fimmu.2021.652864","volume":"12","author":"X Qin","year":"2021","unstructured":"Qin X, Yang H, Zhu F, Wang Q, Shan W. Clinical character of CASPR2 autoimmune encephalitis: A multiple center retrospective study. Front Immunol. 2021;12:652864.","journal-title":"Front Immunol"},{"key":"6549_CR15","doi-asserted-by":"publisher","first-page":"736035","DOI":"10.3389\/fped.2021.736035","volume":"9","author":"C Tan","year":"2021","unstructured":"Tan C, Jiang Y, Zhong M, Hu Y, Hong S, Li X, et al. Clinical features and outcomes in pediatric autoimmune encephalitis associated with CASPR2 antibody. Front Pediatr. 2021;9:736035.","journal-title":"Front Pediatr"},{"key":"6549_CR16","doi-asserted-by":"publisher","first-page":"577008","DOI":"10.1016\/j.jneuroim.2019.577008","volume":"335","author":"M Nosadini","year":"2019","unstructured":"Nosadini M, Toldo I, Tascini B, Bien CG, Parmeggiani L, De Gaspari P, et al. LGI1 and CASPR2 autoimmunity in children: systematic literature review and report of a young Girl with Morvan syndrome. J Neuroimmunol. 2019;335:577008.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"6549_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/brain\/awac276","volume":"146","author":"F G\u00f6vert","year":"2023","unstructured":"G\u00f6vert F, Abrante L, Becktepe J, Balint B, Ganos C, Hofstadt-van Oy U, et al. Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis. Brain. 2023;146(2):657\u201367.","journal-title":"Brain"},{"key":"6549_CR18","doi-asserted-by":"publisher","first-page":"107994","DOI":"10.1016\/j.clineuro.2023.107994","volume":"234","author":"J Moura","year":"2023","unstructured":"Moura J, Sam\u00f5es R, Cardoso M, Sousa AP, Dam\u00e1sio J, Marinho A, et al. Distinct phenotypes in a cohort of anti-CASPR2 associated neurological syndromes. Clin Neurol Neurosurg. 2023;234:107994.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"6549_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ana.26189","volume":"90","author":"S Ramanathan","year":"2021","unstructured":"Ramanathan S, Tseng M, Davies AJ, Uy CE, Paneva S, Mgbachi VC, et al. Leucine-Rich Glioma-Inactivated 1 versus Contactin-Associated Protein-like 2 antibody neuropathic pain: clinical and biological comparisons. Ann Neurol. 2021;90(4):683\u201390.","journal-title":"Ann Neurol"},{"issue":"6","key":"6549_CR20","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s13760-022-02124-7","volume":"123","author":"X Qin","year":"2023","unstructured":"Qin X, Li J, Luo Y, He Y, Xiao X, Tan A, et al. Anti-contactin-associated protein-like 2 antibody autoimmune encephalitis with rapidly progressive parkinsonism: a case report and literature review. Acta Neurol Belg. 2023;123(6):2139\u201346.","journal-title":"Acta Neurol Belg"},{"issue":"10","key":"6549_CR21","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/jnnp-2020-323226","volume":"91","author":"S Mu\u00f1iz-Castrillo","year":"2020","unstructured":"Mu\u00f1iz-Castrillo S, Joubert B, Elsensohn MH, Pinto AL, Saint-Martin M, Vogrig A, et al. Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features. J Neurol Neurosurg Psychiatry. 2020;91(10):1076\u201384.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6549_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241\u201355.","journal-title":"Ann Neurol"},{"issue":"3","key":"6549_CR23","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4103\/0028-3886.349616","volume":"70","author":"PN Suresh Kumar","year":"2022","unstructured":"Suresh Kumar PN, Sajithlal E, Shamsudeen M, Kumar RP. Morvan\u2019s syndrome presenting with psychiatric Manifestations - A case report and review of the literature. Neurol India. 2022;70(3):1207\u20139.","journal-title":"Neurol India"},{"issue":"3","key":"6549_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ana.25310","volume":"84","author":"AS L\u00f3pez-Chiriboga","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, et al. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018;84(3):473\u201380.","journal-title":"Ann Neurol"},{"issue":"9","key":"6549_CR25","first-page":"e45643","volume":"15","author":"KG Koshy","year":"2023","unstructured":"Koshy KG, Iype T, Panicker P. Stimulus-Induced motor afterdischarges in CASPR2 (Contactin-Associated Protein-Like 2)-Positive peripheral nerve hyperexcitability syndrome. Cureus. 2023;15(9):e45643.","journal-title":"Cureus"},{"issue":"11","key":"6549_CR26","first-page":"003544","volume":"9","author":"FPD Barbosa","year":"2022","unstructured":"Barbosa FPD, Vara-Luiz F, Albuquerque A, Marques AV, Spencer V. A case of Anti-Caspr2 autoimmune encephalitis associated with adenocarcinoma of the lung. Eur J Case Rep Intern Med. 2022;9(11):003544.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"3","key":"6549_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s13760-021-01658-6","volume":"122","author":"H Algahtani","year":"2022","unstructured":"Algahtani H, Shirah B, Attar A, Alghaythee H. Contactin-associated protein-like 2 (CASPR2) autoantibody-related pancerebellar syndrome. Acta Neurol Belg. 2022;122(3):805\u20138.","journal-title":"Acta Neurol Belg"},{"issue":"10 Suppl 4","key":"6549_CR28","doi-asserted-by":"publisher","first-page":"S277","DOI":"10.1097\/JTO.0b013e3181f23f04","volume":"5","author":"A Vincent","year":"2010","unstructured":"Vincent A, Irani SR. Caspr2 antibodies in patients with thymomas. J Thorac Oncol. 2010;5(10 Suppl 4):S277\u201380.","journal-title":"J Thorac Oncol"},{"key":"6549_CR29","doi-asserted-by":"publisher","first-page":"1106214","DOI":"10.3389\/fnins.2023.1106214","volume":"17","author":"W Hu","year":"2023","unstructured":"Hu W, Wang E, Fang H, Li L, Yi J, Liu Q, et al. Clinical spectrum of contactin-associated protein 2 autoimmune encephalitis in children. Front Neurosci. 2023;17:1106214.","journal-title":"Front Neurosci"},{"issue":"12","key":"6549_CR30","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","volume":"21","author":"H Pr\u00fcss","year":"2021","unstructured":"Pr\u00fcss H. Autoantibodies in neurological disease. Nat Rev Immunol. 2021;21(12):798\u2013813.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6549_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nri.2016.125","volume":"17","author":"P Brodin","year":"2017","unstructured":"Brodin P, Davis MM. Huma n immune system variation. Nat Rev Immunol. 2017;17(1):21\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"15","key":"6549_CR32","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/diagnostics13152589","volume":"13","author":"M Braczkowski","year":"2023","unstructured":"Braczkowski M, Soszy\u0144ski D, Sierakowska A, Braczkowski R, Kufel K, \u0141abuz-Roszak B. Autoimmune encephalitis with antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the course of Psychoses, neoplastic Diseases, and paraneoplastic syndromes. Diagnostics (Basel). 2023;13(15):2589.","journal-title":"Diagnostics (Basel)"},{"key":"6549_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.005","volume":"281","author":"JS Sunwoo","year":"2015","unstructured":"Sunwoo JS, Lee ST, Byun JI, Moon J, Shin JW, Jeong DE, et al. Clinical manifestations of patients with CASPR2 antibodies. J Neuroimmunol. 2015;281:17\u201322.","journal-title":"J Neuroimmunol"},{"key":"6549_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","volume":"133","author":"SR Irani","year":"2016","unstructured":"Irani SR, Vincent A. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol. 2016;133:185\u201397.","journal-title":"Handb Clin Neurol"},{"issue":"1\u20132","key":"6549_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jns.2014.03.043","volume":"341","author":"CH Lee","year":"2014","unstructured":"Lee CH, Lin JJ, Lin KJ, Chang BL, Hsieh HY, Chen WH, et al. Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma. J Neurol Sci. 2014;341(1\u20132):36\u201340.","journal-title":"J Neurol Sci"},{"issue":"4","key":"6549_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","volume":"267","author":"M Boyko","year":"2020","unstructured":"Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G. Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol. 2020;267(4):1137\u201346.","journal-title":"J Neurol"},{"issue":"1","key":"6549_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, et al. Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol. 2017;82(1):79\u201392.","journal-title":"Ann Neurol"},{"issue":"5","key":"6549_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","volume":"87","author":"A Van Sonderen","year":"2016","unstructured":"Van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, Leypoldt F, K\u00f6rtv\u00e9lyessy P, Wandinger KP, et al. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016;87(5):521\u20138.","journal-title":"Neurology"},{"key":"6549_CR39","doi-asserted-by":"publisher","first-page":"815976","DOI":"10.3389\/fped.2022.815976","volume":"10","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Tan C, Li T, Song X, Ma J, Yao Z, et al. Phenotypic spectrum of CASPR2 and LGI1 antibodies associated neurological disorders in children. Front Pediatr. 2022;10:815976.","journal-title":"Front Pediatr"},{"issue":"3","key":"6549_CR40","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1212\/CPJ.0000000000000978","volume":"11","author":"PS Swayang","year":"2021","unstructured":"Swayang PS, Nalini A, Preethish-Kumar V, Udupa K, Yadav R, Vengalil S, et al. CASPR2-Related Morvan syndrome: Autonomic, Polysomnographic, and neuropsychological observations. Neurol Clin Pract. 2021;11(3):e267\u201376.","journal-title":"Neurol Clin Pract"},{"key":"6549_CR41","volume-title":"StatPearls [Internet]","author":"W Masood","year":"2024","unstructured":"Masood W, Lui F, Sitammagari KK, Morvan Syndrome. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024."},{"issue":"1","key":"6549_CR42","doi-asserted-by":"publisher","first-page":"e200041","DOI":"10.1212\/NXI.0000000000200041","volume":"10","author":"J Benoit","year":"2022","unstructured":"Benoit J, Mu\u00f1iz-Castrillo S, Vogrig A, Farina A, Pinto AL, Picard G, et al. Early-Stage Contactin-Associated Protein-like 2 limbic encephalitis: clues for diagnosis. Neurol Neuroimmunol Neuroinflamm. 2022;10(1):e200041.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"6549_CR43","doi-asserted-by":"publisher","first-page":"103074","DOI":"10.1016\/j.autrev.2022.103074","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N, Butzkueven H, O\u2019Brien TJ, Monif M. Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides. Autoimmun Rev. 2022;21(5):103074.","journal-title":"Autoimmun Rev"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06549-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06549-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06549-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:36:07Z","timestamp":1781631367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06549-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6549"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06549-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case series was granted by the Ethics Commission of the Affiliated Hospital of Zunyi Medical University, and informed consent was obtained from the patients and their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details was obtained from all participating parents and patients. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}